Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | PRKCD | Q05655 | 4/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.34 |
| ▸ | ACE | P12821 | 2/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18949074 | 1.00 | CCR2 (0.40) | CCR2CA1PRKCDACE2NAAA | |
| SCHEMBL18782741 | 0.87 | CA2 (0.38) | CCR2PRKCDCNR1DAGLA | |
| SCHEMBL18782946 | 0.87 | CA2 (0.38) | CCR2PRKCDCNR1DAGLA | |
| SCHEMBL19364679 | 0.85 | CA2 (0.36) | CCR2PRKCDCNR1DAGLA | |
| SCHEMBL18949165 | 0.79 | CA2 (0.34) | CA1PRKCD | |
| SCHEMBL8231382 | 0.77 | TACR1 (0.33) | — | |
| SCHEMBL12986294 | 0.77 | PRKCD (0.37) | CCR2PRKCDNAAADAGLA | |
| SCHEMBL17589087 | 0.75 | CCR2 (0.38) | CCR2CA1PRKCDACE2 | |
| SCHEMBL28986572 | 0.75 | CA1 (0.36) | CCR2CA1PRKCDNAAA | |
| SCHEMBL28986564 | 0.75 | CA1 (0.36) | CCR2CA1PRKCDNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9676802-B2 | Hepatitis C virus inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2017-06-13 | — | — | US | disclosed |